Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Nicole Malachowski ’s post on LinkedIn about recent article by Marwa Omar et al., published in International Journal of Molecular Sciences, adding:
“NETosis is often described as being a ‘double-edged sword’, often used to describe situations where it has the potential for both positive and negative impacts on the host when combating and trying to recover from infectious insults.
Santersus AG has decided to offer a unique and very promising treatment for ‘NETosis dysregulation’ that helps patients remove tissue-damaging NETs from the blood circulation rather than interfering with the NETotic response via systemic drug administration, which can create unwanted side effects and reduce the efficacy of site-specific innate NETosis and NET removal/clearance where it is needed.
‘Most of the studies that have addressed the implications of NETs in protozoan infections have chiefly focused on their protective side, either through trapping or killing.
Challenging this belief, we propose several limitations regarding protozoan-NETs interaction.
One of many is the duality in the functional responses of NETs, in which both the positive and pathological aspects seem to be closely”
Nicole Malachowski, shared a post on LinkedIn:
“ICYMI: A new study came out last week, and it is huge.
FDA-cleared Lyme disease tests have been missing up to 78% of early Lyme cases.
It’s worse than we could have imagined.
How many people are being misdiagnosed?
How much chronic illness has developed because of this?
How much unnecessary suffering has been caused for patients and families?
We need improved diagnostics now.
Read the details from the Bay Area Lyme Foundation here:”
Title: NETosis in Parasitic Infections: A Puzzle That Remains Unsolved
Authors: Marwa Omar, Heba Abdelal
Stay updated on all scientific advances Hemostasis Today.
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque
-
May 22, 2026, 16:25Edward Lee Carter: What Is Changing in Antiplatelet Deprescribing and Why It Matters
-
May 22, 2026, 15:02Robert Brodsky: Can You Stop Thrombosis and Treat CAPS Without Anticoagulation?